| 形式 : |
雑誌 |
| ウェブリンク : |
http://www.currenttherapeuticres.com/article/S0011-393X(15)00016-8/abstract |
|
| 研究チーム : |
San Francisco - Theravance Biopharma |
| 著者 : |
Gu Z, Parra C, Wong A, Nguyen A, Cheung R, Catalano T. |
| 表題 : |
Post-reconstitution Stability of Telavancin with Commonly Used Diluents and Intravenous Infusion Solutions. |
| 引用文献 : |
Current Ther Res ; 77: 105-110. 2015 |
|
| エビデンスレベル : |
|
| 物理的安定性 : |
|
| 化学的安定性 : |
|
| その他の方法 : |
|
| 注釈 : |
|
薬剤一覧
 Telavancin hydrochloride
|
 |
 |
 |
 |
15 mg/ml |
2-8°C |
 |
| 7 |
 |
|
|
|
|
|
15 mg/ml |
20-25°C |
 |
| 12 |
 |
|
|
|
|
 |
15 mg/ml |
2-8°C |
|
| 7 |
|
|
|
|
|
|
15 mg/ml |
20-25°C |
|
| 12 |
|
|
|
|
 |
|
0.6 mg/ml |
2-8°C |
|
| 7 |
|
|
|
|
|
|
0.6 mg/ml |
20-25°C |
|
| 12 |
|
|
|
|
|
|
8 mg/ml |
2-8°C |
|
| 7 |
|
|
|
|
|
|
8 mg/ml |
20-25°C |
|
| 12 |
|
|
|
|
|
 |
0.6 mg/ml |
2-8°C |
|
| 7 |
|
|
|
|
|
|
0.6 mg/ml |
20-25°C |
|
| 12 |
|
|
|
|
|
|
8 mg/ml |
2-8°C |
|
| 7 |
|
|
|
|
|
|
8 mg/ml |
20-25°C |
|
| 12 |
|
|
|
|
|
